Raredimab (Raredex)
Product detail for Raredimab, INN: raredimab. Therapeutic area: Rare Disease. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-009
INN
raredimab
Therapeutic Area
Rare Disease
Status
Active
Owner
Sarah Chen
Created
2022-04-27
Last Updated
2023-09-13
Markets
11
Presentations
| Form | Strength | Route |
|---|---|---|
| Powder for injection | 100 mg/mL | Intravitreal |
| Transdermal patch | 25 mg | Topical |
| Powder for injection | 400 mg | Intramuscular |
| Soft capsule | 200 mg | Subcutaneous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-017 | Thymosilib | thymosilib | 94484-27-2 | biologic | Active |
| SUB-032 | Excipient B | excipient b | 21673-75-1 | small-molecule | Active |
Applications (4)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| SwissMedic-2021-0009 | Switzerland | MAA | In Progress | Marcus Webb | 2022-06-06 |
| Roszdravnadzor-2021-0039 | Switzerland | Type IB Variation | Draft | Sarah Chen | 2023-06-16 |
| SwissMedic-2021-0069 | Switzerland | BLA | Active | James O'Brien | 2022-10-07 |
| Roszdravnadzor-2021-0099 | Switzerland | MAA | Overdue | Aisha Okonkwo | 2023-08-13 |
Markets (11)